Abstract
Characterization of 227 Streptococcus suis strains isolated from pigs during 2010 to 2013 showed high levels of resistance to clindamycin (95.6%), tilmicosin (94.7%), tylosin (93.8%), oxytetracycline (89.4%), chlortetracycline (86.8%), tiamulin (72.7%), neomycin (70.0%), enrofloxacin (56.4%), penicillin (56.4%), ceftiofur (55.9%), and gentamicin (55.1%). Resistance to tetracyclines, macrolides, aminoglycosides, and fluoroquinolone was attributed to the tet gene, erm(B), erm(C), mph(C), and mef(A) and/or mef(E) genes, aph(3')-IIIa and aac(6')-Ie-aph(2″)-Ia genes, and single point mutations in the quinolone resistance-determining region of ParC and GyrA, respectively.
Cite
CITATION STYLE
Gurung, M., Tamang, M. D., Moon, D. C., Kim, S. R., Jeong, J. H., Jang, G. C., … Lim, S. K. (2015). Molecular basis of resistance to selected antimicrobial agents in the emerging zoonotic pathogen Streptococcus suis. Journal of Clinical Microbiology, 53(7), 2332–2336. https://doi.org/10.1128/JCM.00123-15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.